Article

Neuropathic pain (NP) is a significant source of suffering, disability, and
impairment, as well as an enormous cost to society. Historically, pharmacologic
treatment has been limited to drugs approved for other conditions, including
anticonvulsants, antidepressants, antiarrhythmics, and opioids, but in the past 2
decades several drugs have been approved by the Food and Drug Administration
specifically for NP. Understanding the underlying pathophysiology and clinical
presentation of the various causes of NP states facilitates a rational selection
of pharmacologic, interventional, rehabilitative, and psychological options for
reducing pain and maximizing function.
CI - Copyright (c) 2015 American Academy of Physical Medicine and Rehabilitation.
Published by Elsevier Inc.
All rights reserved.

Langue : ANGLAIS